BioSpace News Archive

The Indiana Health Industry Forum is pleased to announce Representative Jackie Walorski as the group’s 2019 Legislator of the Year.

Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients, announced today that CEO Scott Requadt will present at the annual Cell & Gene Meeting on the Mesa to be held October 2-4 in Carlsbad, California.

Kidney innovation leader bolsters leadership team as it expands nationally

Data to be Featured in Oral Presentation at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Advanced Brain Monitoring, Inc. announced $1.5 million awarded by the National Institute on Drug Abuse to develop and validate the Cannabis Impairment Detection Application, a fieldable, easily-applied system to generate a cannabis-related impairment index using wireless EEG/ECG with tablet-based neuropsychological tests.

Significant tumor regression observed with onvansertib in combination with standard-of-care paclitaxel in models of p53-mutated TNBC

ANI Pharmaceuticals, Inc. announced the launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg.

Q BioMed Inc. (OTCQB: QBIO), is pleased to report that it has entered into a settlement agreement with BioNucleonics Inc. to complete the outright acquisition of the non-opioid cancer bone pain drug Strontium-89 Chloride USP

When one is considering tooth removal, innovations in dental implants have made this treatment solution safe, effective and natural looking when done properly.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new AUSTEDO® (deutetrabenazine) data will be presented at the 32nd annual Psych Congress, October 3-6, 2019 in San Diego, California.